The Defense Advanced Research Projects Agency and General Electric are collaborating on a $2.9 million research project to develop bioelectronic devices for type 2 diabetes treatment. "Our project with DARPA aims to find a better alternative that treats diabetes with non-invasive medical devices without the side effects associated with drug treatments," said Victoria Cotero, a global research biologist at GE.
GE, DARPA partner for development of type 2 diabetes treatment device
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.